Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome.
Trahearn N, Sakr C, Banerjee A, Lee SH, Baker AM, Kocher HM, Angerilli V, Morano F, Bergamo F, Maddalena G, Intini R, Cremolini C, Caravagna G, Graham T, Pietrantonio F, Lonardi S, Fassan M, Sottoriva A. Trahearn N, et al. Among authors: pietrantonio f. J Pathol. 2025 Feb;265(2):198-210. doi: 10.1002/path.6378. J Pathol. 2025. PMID: 39788558 Free PMC article.
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy.
Vetere G, Germani MM, Antoniotti C, Salvatore L, Pietrantonio F, Lonardi S, Bensi M, Ghelardi F, Calegari MA, Intini R, Minelli A, Sullo FG, Boccaccio C, Taravella A, Puccini A, Lavacchi D, Noto L, Salati M, Scartozzi M, Cremolini C. Vetere G, et al. Among authors: pietrantonio f. Ther Adv Med Oncol. 2025 Jan 7;17:17588359241299975. doi: 10.1177/17588359241299975. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 39776534 Free PMC article.
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors.
Taieb J, Ambrosini M, Alouani E, Lonardi S, Sinicrope FA, Decraecker M, Boileve A, Hafliger E, Mazard T, Pernot S, Parent P, Ros J, Overman MJ, Jayachandran P, Nasca V, Salvatore L, Guimbaud R, Cremolini C, Tougeron D, Pietrantonio F. Taieb J, et al. Among authors: pietrantonio f. J Immunother Cancer. 2025 Jan 4;13(1):e010424. doi: 10.1136/jitc-2024-010424. J Immunother Cancer. 2025. PMID: 39755579 Free article.
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.
Raimondi A, Lonardi S, Murgioni S, Cardellino GG, Tamberi S, Strippoli A, Palermo F, De Manzoni G, Bencivenga M, Bittoni A, Chiodoni C, Lorenzini D, Todoerti K, Manca P, Sangaletti S, Prisciandaro M, Randon G, Nichetti F, Bergamo F, Brich S, Belfiore A, Bertolotti A, Stetco D, Guidi A, Torelli T, Vingiani A, Joshi RP, Khoshdeli M, Beaubier N, Stumpe MC, Nappo F, Leone AG, Pircher CC, Leoncini G, Sabella G, Airo' Farulla L, Alessi A, Morano F, Martinetti A, Niger M, Fassan M, Di Maio M, Kaneva K, Milione M, Nimeiri H, Sposito C, Agnelli L, Mazzaferro V, Di Bartolomeo M, Pietrantonio F. Raimondi A, et al. Among authors: pietrantonio f. Ann Oncol. 2024 Dec 3:S0923-7534(24)04953-6. doi: 10.1016/j.annonc.2024.11.016. Online ahead of print. Ann Oncol. 2024. PMID: 39637944 Free article.
The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Phase 1b/2a Trial.
Pietrantonio F, Morano F, Niger M, Ghelardi F, Chiodoni C, Palazzo M, Nichetti F, Manca P, Cristarella E, Doldi V, Zaffaroni N, Sabella G, Brambilla N, Benincasa E, Giacovelli G, Vitalini C, Girolami F, Rovati LC. Pietrantonio F, et al. Clin Cancer Res. 2024 Dec 2. doi: 10.1158/1078-0432.CCR-24-2611. Online ahead of print. Clin Cancer Res. 2024. PMID: 39620921
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic Cancer.
Nichetti F, Silvestri M, Agnelli L, Franza A, Pircher C, Rota S, Ambrosini P, Fotia G, Hüllein J, Randon G, Lajer P, Perrone F, Tamborini E, Leoncini G, Coppa J, Busset MDD, Pusceddu S, Milione M, Morano F, Pietrantonio F, Pruneri G, Mazzaferro V, Lipka DB, Köhler BC, Hübschmann D, Fröhling S, de Braud F, Niger M. Nichetti F, et al. Among authors: pietrantonio f. Cancer Med. 2024 Dec;13(23):e70393. doi: 10.1002/cam4.70393. Cancer Med. 2024. PMID: 39618336 Free PMC article.
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon.
Pretta A, Ziranu P, Perissinotto E, Ghelardi F, Marmorino F, Giampieri R, Puci M, De Grandis MC, Lai E, Nasca V, Ciraci P, Puzzoni M, Cerma K, Sciortino C, Taravella A, Pretta G, Giuliani L, Damonte C, Pusceddu V, Sotgiu G, Berardi R, Lonardi S, Bergamo F, Pietrantonio F, Cremolini C, Scartozzi M. Pretta A, et al. Among authors: pietrantonio f. Br J Cancer. 2024 Nov 27. doi: 10.1038/s41416-024-02902-5. Online ahead of print. Br J Cancer. 2024. PMID: 39604610
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.
Macagno M, Pessei V, Congiusta N, Lazzari L, Bellomo SE, Idrees F, Cavaliere A, Pietrantonio F, Raimondi A, Gusmaroli E, Zampino MG, Gervaso L, Ciardiello D, Mondello G, Santoro A, Personeni N, Bonoldi E, Aquilano MC, Valtorta E, Siena S, Sartore-Bianchi A, Amatu A, Bonazzina EF, Bencardino KB, Serini G, Marsoni S, Barault L, Di Nicolantonio F, Maione F. Macagno M, et al. Among authors: pietrantonio f. Diagnostics (Basel). 2024 Nov 5;14(22):2467. doi: 10.3390/diagnostics14222467. Diagnostics (Basel). 2024. PMID: 39594133 Free PMC article.
Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper.
Malapelle U, Angerilli V, Intini R, Bergamo F, Cremolini C, Grillo F, Guerini Rocco E, Latiano TP, Martinelli E, Normanno N, Pagni F, Parente P, Pastorino A, Pietrantonio F, Salvatore L, Lonardi S, Fassan M. Malapelle U, et al. Among authors: pietrantonio f. Crit Rev Oncol Hematol. 2024 Nov 22;206:104574. doi: 10.1016/j.critrevonc.2024.104574. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 39581242 Free article. Review.
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. Randon G, et al. Among authors: pietrantonio f. Lancet Oncol. 2024 Dec;25(12):1539-1550. doi: 10.1016/S1470-2045(24)00580-1. Epub 2024 Nov 15. Lancet Oncol. 2024. PMID: 39557058 Clinical Trial.
377 results